The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Mineralys Therapeutics Inc (NASDAQ: MLYS) closed at $14.15 in the last session, down -2.35% from day before closing price of $14.49. In other words, the price has decreased by -$2.35 from its previous closing price. On the day, 0.64 million shares were traded. MLYS stock price reached its highest trading level at $14.495 during the session, while it also had its lowest trading level at $14.01.
Ratios:
We take a closer look at MLYS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 26.48 and its Current Ratio is at 26.48. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 11, 2025, initiated with a Hold rating and assigned the stock a target price of $15.
On July 10, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $30.Goldman initiated its Buy rating on April 02, 2024, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 30 ’25 when Levy Adam Scott sold 59,925 shares for $14.76 per share. The transaction valued at 884,372 led to the insider holds 132,934 shares of the business.
Levy Adam Scott sold 12,946 shares of MLYS for $181,803 on Jul 28 ’25. The CFO and Secretary now owns 193,666 shares after completing the transaction at $14.04 per share. On Jul 29 ’25, another insider, Levy Adam Scott, who serves as the CFO and Secretary of the company, sold 807 shares for $14.00 each. As a result, the insider received 11,302 and left with 192,859 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLYS now has a Market Capitalization of 922230464 and an Enterprise Value of 579204288.
Stock Price History:
The Beta on a monthly basis for MLYS is -0.29, which has changed by 0.19611156 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, MLYS has reached a high of $18.38, while it has fallen to a 52-week low of $8.24. The 50-Day Moving Average of the stock is -3.46%, while the 200-Day Moving Average is calculated to be 7.60%.
Shares Statistics:
According to the various share statistics, MLYS traded on average about 803.41K shares per day over the past 3-months and 708250 shares per day over the past 10 days. A total of 64.88M shares are outstanding, with a floating share count of 40.63M. Insiders hold about 37.65% of the company’s shares, while institutions hold 66.01% stake in the company. Shares short for MLYS as of 1752537600 were 7867965 with a Short Ratio of 9.79, compared to 1749772800 on 6168786. Therefore, it implies a Short% of Shares Outstanding of 7867965 and a Short% of Float of 15.950000000000001.
